Search for: "Teva Pharmaceuticals" Results 201 - 220 of 1,422
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Nov 2020, 1:41 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA, Inc., is getting attention for potentially “endangering” the practice of skinny labelling. [read post]
22 Oct 2020, 8:23 am by Léon Dijkman
It cites and follows two notable precedents in which similar conclusions were reached: a 2012 decision in proceedings between Boehringer Ingelheim and Teva [here] and a 2016 decision between Novartis and Teva [here]. [read post]
8 Oct 2020, 9:59 pm by Patent Docs
What Quantum of Culpable Conduct Is Required for an ANDA Applicant to Induce Infringement? [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
11 Sep 2020, 7:06 am by Peter Briccetti
The U.S. government filed a False Claims Act case against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
3 Sep 2020, 5:03 am by Apsosredesign
   Claims against Elmiron In March 2020, Teva Pharmaceuticals and Johnson & Johnson were delivered a lawsuit by Kimberly Pelczar. [read post]
30 Aug 2020, 10:19 am by Ben Vernia
According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
24 Aug 2020, 12:00 am by Annsley Merelle Ward
In general, proceedings in the field of mechanical engineering will be classified as “regular” and proceedings in the field of pharmaceuticals as “complex”. [read post]
23 Aug 2020, 11:07 am by Magdaleen Jooste
Kluwer Trademark Blog reported on two applications by Teva Pharmaceutical Industries have now suffered that fate again. [read post]
13 Aug 2020, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
10 Aug 2020, 8:22 am by Agnieszka Sztoldman (Taylor Wessing)
Two applications by Teva Pharmaceutical Industries have now suffered that fate again. [read post]
9 Aug 2020, 12:32 pm by Nedim Malovic
It also held that also a slogan can be capable of indicating the commercial origin of the goods or services in question, when that sign is not merely an ordinary advertising message, but rather possesses a certain degree of originality or resonance.BackgroundWith an application filed in August 2018, the Applicant – Teva Pharmaceutical Industries – sought to register ‘Weniger Migräne. [read post]
3 Aug 2020, 7:02 am by Elizabeth McAuliffe (Bristows)
Where there are specialists with a focus on the kind of work with which a patent is concerned, they are the relevant addressees of the patent and their specialist skills are attributed to the notional skilled person, even if the patent might also be of a broader application and of interest to non-specialists (Medimmune Ltd v Novartis Pharmaceuticals UK Ltd [2013] RPC 27). [read post]
In this article, we report on a case started in 2012, which came to its conclusion in 2020 with a second instance judgment that awarded the holder of a significant pharmaceutical patent, EUR 1.5 mio damages approximately to compensate an infringement that lasted 40 days. [read post]
18 May 2020, 3:37 am by Deb Givens
The company, Teva Pharmaceutical Industries, is betting that in the middle of a deadly pandemic, the Trump administration won’t dare to come down hard on the largest supplier of generic drugs in the United States. [read post]